Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Blood group H tetraose type II | Blood group H tetraose type II is a pivotal and indispensable element, primarily finding its application in comprehensive research endeavors pertaining to blood antigens and the intricacies of the immune system. Synonyms: Fuca-2Galb-4GlcNAcb-3Gal. CAS No. 1352644-16-6. Molecular formula: C26H45NO20. Mole weight: 691.63. |  |
| Difucosyllacto-N-tetraose | | |
| Disialyllacto-N-tetraose | Disialyllacto-N-tetraose is a human milk oligosaccharide that prevents necrotising enterocolitis in neonatal rats [1]. Uses: Scientific research. Group: Natural products. CAS No. 61278-38-4. Pack Sizes: 1 mg. Product ID: HY-N11503. |  |
| Disialyllacto-N-tetraose | Disialyllacto-N-tetraose is a vital compound in biomedicine used for research purposes. It plays a key role in exploring the treatment of certain diseases and conditions. This product acts as an important tool in developing therapeutic strategies linked to neurodegenerative disorders, cancer, and autoimmune diseases. Synonyms: DSLNT; a-NeuNAc-(2-3)-b-Gal-(1-3)-[a-NeuNAc-(2-6)]-b-GlcNAc-(1-3)-b-Gal-(1-4)-Glc; α-Neu5Ac-(2->3)-β-Gal-(1->3)-[α-Neu5Ac-(2->6)]-β-GlcNAc-(1->3)-β-Gal-(1->4)-Glc; (6R)-5-Acetamido-3,5-didesoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-β-L-threo-hex-2-ulopyranonosyl-(2->6)-[(6R)-5-acetamido-3,5-didesoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-β-L-threo-hex-2-ulopyranonosyl-(2->3)-β-D-galactopyranosyl-(1->3)]-2-acetamido-2-desoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-galactopyranose. Grades: ≥95%. CAS No. 61278-38-4. Molecular formula: C48H79N3O37. Mole weight: 1290.14. | |
| Globo-N-tetraose | Globo-N-tetraose is a potential compound exhibiting promising properties in the research of cancer, specifically in targeting cancer cells expressing the Globo H antigen. By blocking the interaction between Globo H and corresponding antibodies, Globo-N-tetraose shows potential as an antitumor compound. Synonyms: GalNAc-b-1,3-Gal-a-1,4-Gal-b-1,4-Glc. CAS No. 75660-79-6. Molecular formula: C26H45NO21. Mole weight: 707.63. | |
| Globo-N-tetraose-APD-HSA | | |
| Globo-N-tetraose GEL | | |
| Glycyl-disialyllacto-N-tetraose | Glycyl-disialyllacto-N-tetraose is a bioactive compound found in breast milk, acting as a prebiotic promoting the growth of beneficial gut bacteria. Molecular formula: C50H83N5O37. Mole weight: 1346.21. | |
| Glycyl-lacto-N-tetraose | Glycyl-lacto-N-tetraose is an extensively pharmaceutically developed biomedical compound, exhibiting immense potential in studying a plethora of ailments encompassing cancer and autoimmune disorders. Synonyms: Glycyl-lacto-N-tetraose (LNT-gly); Galβ1-3GlcNAcβ1-3Glaβ1-4Glc-Gly-NH2. Grades: 95%. Molecular formula: C28H49N3O21. Mole weight: 763.70. | |
| Glycyl-sialyllacto-N-tetraose a | Glycyl-sialyllacto-N-tetraose a is a remarkable biomedical compound, used for studying respiratory syncytial virus (RSV) and influenza virus infections. Molecular formula: C39H66N4O29. Mole weight: 1054.95. | |
| Glycyl-sialyllacto-N-tetraose b | Glycyl-sialyllacto-N-tetraose b, an extraordinary biomedical agent renowned for its profound applications instduying bacterial infections and inflammation-related maladies. Molecular formula: C39H66N4O29. Mole weight: 1054.95. | |
| Glycyl-sialyllacto-N-tetraose c | Glycyl-sialyllacto-N-tetraose c is a gastroprotective bioactive derivative employed in biomedical applications to study diverse inflammatory ailments. Its innate anti-inflammatory characteristics enhance its applications in studying afflictions including rheumatoid arthritand inflammatory bowel disease. Molecular formula: C39H66N4O29. Mole weight: 1054.95. | |
| Lacto-N-neo-tetraose | synthetic, ?85% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| Lacto-N-tetraose | Lacto-N-tetraose is a fascinating carbohydrate compound, aiding in studying gastrointestinal disorders and specific cancer variants. Synonyms: Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; LNT; R-lactotetraose-HSA; Beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose; BetaD-Galp(1?3)betaD-GlcpNAc(1?3)betaD-Galp(1?4)D-Glcp; 4-O-[3-O-[3-O-beta-D-Galactopyranosyl-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-beta-D-galactopyranosyl]-D-glucopyranose. Grades: ≥90%. CAS No. 14116-68-8. Molecular formula: C26H45NO21. Mole weight: 707.63. | |
| Lacto-N-tetraose | Lacto-N-tetraose is the significant core structure of human milk oligosaccharides (HMOs) naturally existing in human milk. Lacto-N-tetraose is consist of galactose, N-acetylglucosamine, and glucose moieties. Lacto-N-tetraose has prebiotic effect, immune regulatory effect, anti-inflammatory effects, intestinal cell responses regulatory effect, antibacterial activity and antiviral activity. Lacto-N-tetraose has been widely added to infant formula [1]. Uses: Scientific research. Group: Natural products. CAS No. 14116-68-8. Pack Sizes: 5 mg; 10 mg. Product ID: HY-N9448. | |
| Lacto-N-tetraose-a-APD-HSA | | |
| Lacto-N-tetraose-APD-KLH | Lacto-N-tetraose-APD-KLH is a fascinating biomedical compound, exhibiting profound immunostimulatory properties. This remarkable compound works tirelessly to instigate the generation of bespoke antibodies, specifically tailored to study recalcitrant pathogens or malignancies. | |
| Lacto-N-tetraose-BSA | | |
| Lacto-N-tetraose-GEL | Lacto-N-tetraose-GEL is a remarkable biomedical compound, unleashing its formidable antibacterial prowess. This unique gel formulation graciously diffuses its potency to effectively thwart Gram-positive and Gram-negative strains alike. | |
| Lacto-N-tetraose LNT | Galb1®3GlcNAcb1®3Galb1®3Glc core structure. Lewisx tumor-associated trisaccharide antigen, E- and P-selectin ligand, anti-inflammatory agent. CAS No. 14116-68-8. Product ID: 3-00426. Molecular formula: C26H45NO21. Mole weight: 707.64. Reference: Science, 260, 906, 1993; J. Exp. Med., 178, 623, 1993. |  |
| N-Acetylneuraminyl-fucosyllacto-N-neo-tetraose from human milk | N-Acetylneuraminyl-fucosyllacto-N-neo-tetraose from human milk. Group: Polysaccharide. CAS No. 111216-36-5. Product ID: (2R,4S,5R,6R)-5-acetamido-2-[[(2R,3R,4S,5R,6S)-6-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid. Molecular formula: 1145g/mol. Mole weight: C43H72N2O33. CC1C (C (C (C (O1)OC2C (C (OC (C2OC3C (C (C (C (O3)CO)O)OC4C (C (C (C (O4)CO)OC5C (C (C (C (O5)COC6 (CC (C (C (O6)C (C (CO)O)O)NC (=O)C)O)C (=O)O)O)O)O)O)NC (=O)C)O)CO)O)O)O)O)O. InChI=1S/C43H72N2O33/c1-10-21 (54)26 (59)28 (61)39 (69-10)77-36-30 (63)37 (65)70-17 (8-49)33 (36)75-41-31 (64)35 (24 (57)15 (6-47)71-41)76-38-20 (45-12 (3)51)25 (58)32 (16 (7-48)72-38)74-40-29 (62)27 (60)23 (56)18 (73-40)9-68-43 (42 (66)67)4-13 (52)19 (44-11 (2)50)34 (78-43)22 (55)14 (53)5-46/h10, 13-41, 46-49, 52-65H, 4-9H2, 1-3H3, (H, 44, 50) (H, 45, 51) (H, 66, 67)/t10-, 13-, 14+, 15+, 16+, 17+, 18+, 19+, 20+, 21+, 22+, 23-, 24-, 25+, 26+, 27-, 28-, 29+, 30+, 31+, 32+, 33-, 34+, 35-, 36+, 37?, 38-, 39-, 40-, 41-, 43+/m0/s1. HSYHUIKGLHMONM-RDNIXPOZSA-N. |  |
| Sialylfucosyllacto-N-tetraose | Sialylfucosyllacto-N-tetraose is a biomedical innovation, standing as a potent compound in studying intricate viral and microbial afflictions. Functioning as an immunomodulatory compound, it demonstrating impressive efficacy in studying the labyrinth of influenza viruses. Synonyms: Sialyl-LNF II; Sialyl-lea (19-9 antigen); Neu5Ac(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc. CAS No. 84061-53-0. Molecular formula: C43H72N2O33. Mole weight: 1145.03. | |
| lacto-N-biosidase | The enzyme from Streptomyces specifically hydrolyses the terminal lacto-N-biosyl residue (β-D-Gal-(1?3)-D-GlcNAc) from the non-reducing end of oligosaccharides with the structure β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?R). Lacto-N-hexaose (β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed to form first lacto-N-tetraose plus lacto-N-biose, with the subsequent formation of lactose. Oligosaccharides in which the non-reducing terminal Gal or the penultimate GlcNAc are replaced by fucose or sialic acid are not substrates. Asialo GM1 tetraose (β-D-Gal-(1?3)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed very slowly, but lacto-N-neotetraose (β-D-Gal-(1?4)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is not a substrate. Group: Enzymes. Enzyme Commission Number: EC 3.2.1.140. CAS No. 146359-52-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3823; lacto-N-biosidase; EC 3.2.1.140; 146359-52-6. Cat No: EXWM-3823. |  |
| LS-Tetrasaccharide a | LS-Tetrasaccharide a, a synthetic carbohydrate with potent therapeutic potential in cancer, diabetes and neuropathic pain, exerts its anti-angiogenic and anti-inflammatory activity by blocking the binding of key molecules, VEGF and IL-8, to cell surface receptors. This novel compound exhibits remarkable benefits against these debilitating conditions, underscoring its potential as a unique therapeutic agent and promising avenue of research. Synonyms: LSTa; Sialyllacto-N-tetraose a; Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc. CAS No. 64003-58-5. Molecular formula: C37H62N2O29. Mole weight: 998.88. | |
| LS-tetrasaccharide a sodium salt | LS-tetrasaccharide is a groundbreaking sodium salt compound, hailed for its incomparable efficacy in studying lysosomal storage diseases including the dreaded mucopolysaccharidosis (MPS). Synonyms: N-Acetylneuraminyllacto-N-tetraose a; Sialyllacto-N-tetraose a; LST a; a-NeuNAc-(2-3)-b-Gal-(1-3)-b-GlcNAc-(1-3]-b-Gal-(1-4)-Glc. CAS No. 64003-53-8. Molecular formula: C37H61N2O29Na. Mole weight: 1020.87. | |
| LS-tetrasaccharide b | LS-tetrasaccharide b, an exemplary biomedicine product, possesses noteworthy applicability in addressing the formidable challenge posed by lysosomal storage diseases (LSDs) encompassing Gaucher disease and Fabry disease. Synonyms: LST b; Sialyllacto-N-tetraose b; a-NeuNAc-(2-6)-(b-D-Gal-[1-3])-b-D-GlcNAc-(1-3)-b-D-Gal-(1-4)-Glc; N-Acetylneuraminyllacto-N-tetraose b; O-(N-acetyl-alpha-neuraminosyl)-(2->6)-O-[beta-D-galactopyranosyl-(1->3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-Glucose. Grades: 95%. CAS No. 64003-54-9. Molecular formula: C37H62N2O29. Mole weight: 998.88. | |
| LS-tetrasaccharide c | LS-tetrasaccharide c is an extraordinary biomedical compound, bestowed with the exceptional ability to impede ceramide glycosyltransferase, a vital actor implicated in the relentless march of tumor propagation and metastasis. Synonyms: LSTc; Sialyllacto-N-tetraose c; a-NeuNAc-(2-6)-b-Gal-(1-4)-b-GlcNAc-(1-3)-b-Gal-(1-4)-Glc; N-Acetylneuraminyllacto-N-neo-tetraose c; alpha-Neu5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp; 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-beta-non-2-ulonosyl-(2->6)-beta-D-galactosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucosyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose. Grades: 95%. CAS No. 64003-55-0. Molecular formula: C37H62N2O29. Mole weight: 998.88. | |
| Sialyllacto-N-fucopentaose V | Sialyllacto-N-fucopentaose V is a profoundly influential carbohydrate compound with formidable anti-tumor properties. Moreover, its pivotal contribution to investigating viral-host cell dynamics unveils profound elucidation on viral pathogenesis. Synonyms: Fuc(a1-2)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc(b1-3)Gal(b1-4)Glc; Monofucosyl monosialyllacto-N-tetraose; Sialyl LNF V. CAS No. 89458-13-9. Molecular formula: C43H72N2O33. Mole weight: 1145.03. | |
| 4-Nitrophenyl b-globo-N-tetraoside | 4-Nitrophenyl b-globo-N-tetraoside is a valuable compound widely used in the biomedical industry. This product acts as a substrate for enzymes involved in the degradation of glycolipids, playing a crucial role in studies related to lysosomal storage diseases. Its ability to mimic glycolipid structures aids in investigating disease mechanisms and developing potential therapeutic strategies. Synonyms: GalNAc-b-1,3-Gal-a-1,4-Gal-b-1,4-Glc-b-pNP. CAS No. 1134635-03-2. Molecular formula: C32H48N2O23. Mole weight: 828.72. | |
| 4-Nitrophenyl lacto-N-tetraoside | 4-Nitrophenyl lacto-N-tetraoside is a crucial compound utilized in biomedical research for studying cellular processes and investigating glycosylation-related diseases. It acts as a substrate for enzymes involved in glycosylation reactions and aids in the identification and characterization of these enzymes. Its application in drug development and disease diagnosis holds promise for understanding and treating glycosylation disorders. Synonyms: LNT-pNP Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc-b-pNP. CAS No. 148705-09-3. Molecular formula: C32H48N2O23. Mole weight: 828.72. | |
| Endo-β-galactosidase from Bacteroides fragilis, Recombinant | Endo-β-Galactosidase is an enzyme that hydrolyzes internal β-galactosidic linkages of oligosaccharides in poly-N-acetyl-lactosamine structures. This enzyme resembles the Escherichia freundii enzyme due to its specificity towards bovine corneal keratan sulphate, milk oligosaccharides and the glycolipids lacto-N-neotetraosylceramide and lacto-N-tetraosylceramide. Group: Enzymes. Synonyms: β-Galactosidase bacterial; Keratanase; Endo-β-galactosidase; keratan sulfate endogalactosidase; keratan-sulfate 1,4-β-D-galactanohydrolase; EC 3.2.1.103. Enzyme Commission Number: EC 3.2.1.103. CAS No. 55072-01-0. Endo-β-galactosidase. Mole weight: ~32 kDa. Activity: >14 U/ml; Specific Activity: >140 U/mg protein. Storage: 2-8°C. Form: Sterile-filtered in 20 mM Tris-HCl, pH 7.5. Source: E. coli. Species: Bacteroides fragilis. β-Galactosidase bacterial; Keratanase; Endo-β-galactosidase; keratan sulfate endogalactosidase; keratan-sulfate 1,4-β-D-galactanohydrolase; EC 3.2.1.103. Cat No: NATE-1413. | |
| GA1-Ganglioside | GA1-Ganglioside is a potent compound used to study Gangliosidosis Type 1, a rare and progressive genetic disorder. Derived from natural sources, this product can replenish the deficient GA1-ganglioside enzyme. Synonyms: Ganglio-N-tetraosylceramide; Ceramide tetrahexoside; GgOse4Cer; asialo-GM1. CAS No. 71012-19-6. Molecular formula: C62H114N2O23. Mole weight: 1255.6. | |
| N-Acetylglucosamine endo-β-galactosidase 16C from Clostridium perfringens, Recombinant | Endo-β-Galactosidase is an enzyme that hydrolyzes internal β-galactosidic linkages of oligosaccharides in poly-N-acetyl-lactosamine structures. This enzyme resembles the Escherichia freundii enzyme due to its specificity towards bovine corneal keratan sulphate, milk oligosaccharides and the glycolipids lacto-N-neotetraosylceramide and lacto-N-tetraosylceramide. Group: Enzymes. Synonyms: β-Galactosidase bacterial; Keratanase; Endo-β-galactosidase; keratan sulfate endogalactosidase; keratan-sulfate 1,4-β-D-galactanohydrolase; EC 3.2.1.103. Enzyme Commission Number: EC 3.2.1.-. Purity: >90% by SDS-PAGE. Endo-β-galactosidase. Mole weight: 33.7 kDa. Storage: This enzyme is shipped at room temperature but should be stored at -20 °C. Form: 35 mM NaHepes buffer, pH 7.5, 750 mM NaCl, 200 mM imidazol, 3.5 mM CaCl2, 0.02% sodium azide and 25% (v/v) glycerol. Source: E. coli. Species: Clostridium perfringens. β-Galactosidase bacterial; Keratanase; Endo-β-galactosidase; keratan sulfate endogalactosidase; keratan-sulfate 1,4-β-D-galactanohydrolase; EC 3.2.1.-; N-Acetylglucosamine endo-β-galactosidase 16C. Cat No: NATE-1412. | |
Our database is helping our users find suppliers everyday.
